
How Endometriosis Can Affect Your Bowel and Digestion
Your digestive symptoms can be real endometriosis—here’s what research suggests about diagnosis and options

Digestive symptoms are some of the most confusing (and dismissible) parts of endometriosis. You may be told it’s IBS, stress, hemorrhoids, “something you ate,” or unrelated to pelvic pain—especially if your colonoscopy looks normal. But endometriosis can affect the bowel wall and nearby pelvic structures, creating symptoms that feel gastrointestinal even when the problem isn’t primarily “inside” the bowel.
This article pulls together findings from multiple recent clinical reviews and surgical case series on how endometriosis can affect your bowel and digestion, why it’s often hard to diagnose, and what management typically looks like. The big theme across the evidence: bowel endometriosis is treatable, but it’s also high-stakes and anatomy-dependent, so the best outcomes tend to come from careful pre-op mapping and a team that includes both gynecology and bowel-surgery expertise.
How endometriosis affects the bowel (and why symptoms can be weird)
“Bowel endometriosis” usually means deep infiltrating endometriosis (DIE) involving the outer bowel surface and/or deeper layers (often the muscular layer). The rectum and rectosigmoid area are the most commonly involved sites in multiple cohorts and reviews. In one surgical cohort, rectal involvement dominated (over 80%), and another bowel resection series similarly found most lesions clustered in the sigmoid/rectosigmoid/upper rectum—areas anatomically close to the uterus, ovaries, and pouch of Douglas.
That location matters because symptoms can come from several mechanisms at once:
- Inflammation and irritation around the bowel
- Fibrosis/scarring that tethers bowel to other organs
- Narrowing (stenosis) that changes stool passage and causes cramping
- Nerve involvement in deep disease that amplifies pain signals
This also explains why bowel symptoms can overlap with adenomyosis and “classic” pelvic endometriosis: bowel disease often travels with other sites of endometriosis. Notably, one cohort reported adenomyosis in about two-thirds of patients with bowel endometriosis, especially among those with rectal involvement—important if you have heavy bleeding and uterine tenderness plus bowel symptoms and are trying to figure out what’s driving what.
Common bowel and digestive symptoms (and what patterns raise suspicion)
Bowel endometriosis can look like many things. Across patient-focused guidance in recent reviews and real-world case series, symptoms that commonly raise suspicion include:
- Pain with bowel movements (dyschezia), especially deep, sharp, or “tearing”
- Constipation, diarrhea, or alternating patterns, often cyclical
- Bloating and cramping, sometimes concentrated low in the pelvis
- Nausea/vomiting in more severe flares
- Rectal bleeding, particularly if it tracks with the menstrual cycle
One reason people get dismissed is that symptoms aren’t always textbook. Case reports and diagnostic discussions emphasize that bowel endometriosis can present atypically—such as painless rectal bleeding—or may not be clearly cyclical. It can even mimic rectal cancer or other rectal masses on imaging, which is frightening but underscores the importance of getting the diagnosis right.
When symptoms could be urgent
Most bowel symptoms are chronic and fluctuating, but bowel endometriosis can—rarely—present with significant obstruction. A reported case of complete large bowel obstruction showed how the disease can act like a tumor while standard mucosal biopsies stay normal. If you have severe abdominal distension, inability to pass stool/gas, vomiting, or escalating pain, seek urgent care.
Why colonoscopy is often “normal” (even when the bowel is involved)
A key diagnostic frustration is this: bowel endometriosis often spares the inner lining (mucosa). Colonoscopy mainly evaluates the mucosa. So you can have significant disease in deeper layers and still have:
- a normal-looking colonoscopy, or
- a “bulge” that looks submucosal, with biopsies that come back negative
This isn’t just theoretical. In a 2026 surgical series of intestinal endometriosis, preoperative colonoscopy biopsies almost never confirmed the diagnosis (only 1 positive among those biopsied), despite abnormal endoscopic findings in many patients. Multiple papers echo the same practical point: a negative colonoscopy biopsy does not necessarily rule out bowel endometriosis when symptoms and imaging suggest deep disease.
So what is colonoscopy good for? Often, it’s part of ruling out other causes of bleeding, anemia, inflammatory bowel disease, or malignancy—especially if you have red-flag symptoms. But it may not be the test that “proves” bowel endometriosis.
Imaging and testing: what helps map bowel endometriosis before treatment?
Because tissue diagnosis can be difficult without surgery, many clinical pathways rely on expert imaging plus symptoms to plan treatment.
Transvaginal ultrasound (TVUS): often first-line—operator skill matters
A recent multidisciplinary review describes TVUS as a preferred first-line tool with high diagnostic performance in experienced hands, citing meta-analytic ranges with high specificity and variable sensitivity. Practically: a positive expert TVUS can be very helpful, but a negative scan doesn’t always end the story—especially if symptoms are strong or disease is higher in the bowel.
MRI: often used for mapping and surgical planning
MRI is frequently used to map deep disease and its relationship to nearby structures. In a surgical cohort, pelvic MRI had a high “positivity rate” among those who ultimately had surgically confirmed bowel endometriosis—suggesting MRI is often informative in the right clinical context. MRI is also useful for follow-up in people treated medically; one conservatively managed rectosigmoid lesion was tracked with MRI showing major shrinkage after hormonal therapy.
Endoscopic ultrasound (EUS): can see bowel wall layers (and sometimes get tissue)
EUS can be particularly valuable when the question is, “Is this lesion in the bowel wall, and which layer?” In one cohort, EUS had a high positivity rate among surgically confirmed cases. And in a case where a rectal mass looked malignant on MRI and colonoscopy biopsies were normal, EUS-guided fine needle aspiration (FNA) obtained deeper tissue and confirmed endometriosis. This isn’t routine for everyone, but it highlights an option when standard biopsies are non-diagnostic and the lesion is accessible.
Pelvic exam still matters
Several cohorts report high rates of abnormal findings on bimanual/trimanual exam in confirmed disease. A normal exam doesn’t exclude bowel endometriosis, but tenderness, nodularity, or reduced uterine mobility can add weight to suspicion and guide imaging.
Management options: medications, surgery, or both
The combined evidence across reviews and clinical cohorts points to a realistic message: bowel endometriosis is usually managed with a stepwise, individualized plan based on symptoms, degree of narrowing, fertility goals, and how deep/large the lesion is.
Struggling with Digestive Pain? Get Help Now
Our specialists are here to help you understand your condition and explore your treatment options.
Schedule Your Visit1) Hormonal suppression: often helpful for symptoms, not always a “forever fix”
Multiple papers support hormonal therapy as a meaningful option—particularly when symptoms are driven by inflammatory activity rather than fixed narrowing. One review notes symptom improvement in some patients, especially when bowel stenosis is less severe (for example, <60% narrowing as cited by the authors). Progestins are discussed as potentially improving some GI symptoms, and GnRH analogues are commonly used in real-world pathways (including as postoperative suppression in a surgical cohort).
Real-life responses vary. A case report described dramatic shrinkage of a large rectal/rectosigmoid endometrioma and an ovarian endometrioma after six months of a GnRH analogue, followed by dienogest maintenance, with stable imaging on follow-up. On the other hand, another case showed progression of additional lesions despite GnRH therapy, ultimately requiring major surgery. Together, these reports reinforce a patient-centered point: some people get substantial relief and lesion regression on medication; others don’t—and you can’t always predict which group you’ll be in.
When medication is most appealing:
- You’re not trying to conceive right now
- Symptoms are bothersome but not causing obstruction
- Imaging suggests disease is present but not dangerously narrowing the bowel
- You want to try less invasive options first
2) Surgery: effective for many, but the “type” of bowel surgery matters
When symptoms persist despite medical therapy, when there’s significant stenosis, or when anatomy is distorted, surgery may be recommended. Across the two major reviews, bowel surgery is typically described in three categories:
- Shaving excision (removing disease off the bowel surface)
- Discoid (disc) excision (full-thickness removal of a localized nodule)
- Segmental resection (removing a segment of bowel and reconnecting it)
A consistent theme in recent reviews is trying to be as conservative as safely possible, because more extensive resections tend to carry higher risks. Reviews argue that shaving (and often discoid excision) can have lower complication rates in selected patients, while segmental resection is usually reserved for more severe or extensive disease.
However, it’s important not to oversimplify: conservative surgery may leave microscopic disease behind in some cases, and outcomes depend heavily on lesion characteristics and surgeon expertise. A 2026 review also emphasizes that evidence comparing these techniques is limited by inconsistent definitions and underreporting of outcomes that matter to patients.
What are the real complication risks?
Complication rates vary widely by center, technique, and patient selection. Some specialized cohorts report very low complication rates, while others document meaningful risks. For example, a 2026 bowel resection series reported both early complications (including an anastomotic leak and ileus) and late complications such as anastomotic stenosis, intestinal stenosis, and a rectovaginal fistula—events that can be life-altering. This doesn’t mean surgery is “bad,” but it does mean you deserve clear counseling on which complications are most relevant to the exact operation being proposed.
Functional outcomes matter (not just pain)
One review highlights a gap patients should know about: studies often focus on pain and recurrence while inconsistently measuring long-term function, including:
- bowel urgency/incontinence patterns (sometimes grouped under LARS-like symptoms)
- bladder emptying problems/urinary retention
- sexual function changes
These issues should be part of pre-op planning and follow-up, not an afterthought.
3) Multidisciplinary care isn’t optional—it’s risk reduction
Across the most clinically oriented review papers, the recommendation is consistent: bowel endometriosis care is safest and most effective when gynecologic and gastrointestinal/colorectal expertise are both involved, especially when surgery is on the table. This matters for surgical planning (what to remove and how), complication management, and aligning treatment with fertility goals.
What to expect on a timeline (and how follow-up often works)
There isn’t one universal timeline, but patterns across studies suggest:
- Medication trials are often assessed over months (for example, 3–6 months), with symptom tracking and sometimes repeat imaging if a lesion was visible initially.
- Post-surgery symptom improvement can begin early; one cohort reported significant pain-score improvements by 1 month and continuing at 6 months across multiple pain domains, including painful bowel movements.
- Many surgical pathways include postoperative hormonal suppression, which may help reduce recurrence risk or control residual disease—though comparative evidence for the “best” regimen is limited.
Recurrence rates are hard to compare because definitions vary, but some single-center cohorts report relatively low observed recurrence over follow-up—important but not a guarantee, since recurrence depends on completeness of excision, disease biology, and whether hormonal suppression is used.
Practical takeaways: how to advocate for yourself
Use these questions to guide a more productive specialist visit:
- What is your level of concern for bowel endometriosis based on my symptoms and exam?
- Which imaging is best for me: expert TVUS, MRI, and/or EUS? Who will interpret it?
- If my colonoscopy biopsies are negative, does that meaningfully change your suspicion (and why)?
- Are you recommending medication, surgery, or both—and what is the goal (pain control, preventing obstruction, fertility planning)?
- If surgery is proposed, which approach (shaving, discoid, segmental resection) and what factors are driving that choice?
- What are my risks for anastomotic leak, stenosis, rectovaginal fistula, or need for a temporary stoma?
- How will you track outcomes that matter to me: pain, bowel function, bladder function, sexual function, and fertility?
- Will my case be managed by a multidisciplinary team (endometriosis surgeon + colorectal surgeon), and who handles complications if they occur?
What we still don’t know (and why experiences differ so much)
Even though the overall management framework is consistent, major uncertainties remain:
Evidence comparing surgical techniques is limited by a lack of large randomized trials, variable definitions (what counts as “shaving,” what counts as “recurrence”), and inconsistent reporting of long-term functional outcomes. In other words, even when studies agree that conservative surgery often has lower complication rates, it’s not always possible to say exactly who will do best with which procedure.
We also still can’t reliably predict response to hormonal therapy for an individual. Some people have dramatic symptom relief and lesion regression; others have persistent symptoms or progression. Factors like lesion depth, degree of stenosis, coexisting adenomyosis, and overall burden of deep disease likely contribute, but they’re not yet precise “predictors.”
What is clear across the combined research: bowel endometriosis is real, it can masquerade as GI disease, and outcomes improve when diagnosis and treatment are planned intentionally—with the right imaging, the right expertise, and a plan that fits your goals.
References
Tsuei, Nezhat, Amirlatifi et al.. Comprehensive Management of Bowel Endometriosis: Surgical Techniques, Outcomes, and Best Practices. Journal of Clinical Medicine. 2025. PMID: 39941647 PMCID: PMC11818743
Carvalho, Cardoso, Pires et al.. Diagnosis of Bowel Endometriosis Using Endoscopic Ultrasound-guided Fine Needle Aspiration. The Korean Journal of Gastroenterology. 2023. PMID: 36695067 PMCID: PMC12285469
Ro, Kojima, Takahashi et al.. Characteristics and Surgical Outcomes of Patients with Intestinal Endometriosis Undergoing Bowel Resection. Journal of the Anus, Rectum and Colon. 2026. PMID: 41623603 PMCID: PMC12854292
Deborah, Tiang, Bin Masood. Rectosigmoid Endometrioma Mimicking Rectal Hematoma: A Diagnostic Dilemma Managed Conservatively. Cureus. 2025. PMID: 41625871 PMCID: PMC12858373
Jiao, Feng, Liu. Clinical diagnosis and treatment of bowel endometriosis and the distribution characteristics of lesions. BMC Women's Health. 2025. PMID: 41469645 PMCID: PMC12860066
Fruscalzo, Vallée, Marti et al.. Comprehensive Approaches to Endometriosis Management and Targeted Strategies for Bowel Endometriosis. Journal of Clinical Medicine. 2026. PMID: 41682719 PMCID: PMC12898175
Quick Answers
How rare is endosalpingiosis?
Endosalpingiosis is generally considered uncommon, but “how rare” it is depends heavily on who’s being studied and how it’s found. Many cases are discovered incidentally on pathology—meaning tissue is identified under the microscope after surgery done for other reasons—so it’s likely underrecognized in the general population. In other settings (like surgical cohorts), it may appear more often simply because more tissue is being sampled and examined carefully.
What matters most for patients is that endosalpingiosis can be confused with endometriosis on imaging or even at surgery, yet it doesn’t always behave the same way clinically. If you’ve been told you have endosalpingiosis and you also have pelvic pain, bowel/bladder symptoms, or fertility concerns, our team can help interpret what that finding means in the context of your symptoms and operative/pathology reports. You’re welcome to explore our educational content on related endometriosis and uterine conditions, and reach out to schedule a consultation if you want a personalized plan.
Can endometriosis cause a painful bump near the anus?
Yes. Endometriosis can contribute to pain and pressure around the rectum and anal area, especially when disease involves the rectum/rectosigmoid region or nearby tissues. Many patients describe deep pain with bowel movements, rectal pressure, or symptoms that flare around their cycle, and those patterns can fit bowel or deep infiltrating endometriosis.
That said, a sensitive bump on the anus itself is more often something else (like a hemorrhoid, fissure, skin infection/abscess, or another localized anal/skin condition). In some cases, pelvic disease can coexist with these issues, which is why we don’t assume every finding is endometriosis—or dismiss it as “nothing.”
If you’re noticing a new, persistent, or worsening bump—especially if it’s very tender, draining, bleeding, or associated with fever—we want to evaluate the full picture. Our team can sort out whether your symptoms point toward bowel endometriosis, a separate anorectal condition, or both, and plan next steps such as a focused exam and, when appropriate, expertly interpreted imaging to map possible deep disease.
How does estrogen affect the endometrium?
Estrogen is one of the main hormones that drives endometrial growth. In the first half of the menstrual cycle, rising estrogen signals the endometrium to thicken and rebuild after a period, preparing the uterus for a possible pregnancy. It also influences the local immune and inflammatory environment in the uterus, which is part of why hormonal shifts can change bleeding patterns and pain.
When estrogen’s growth signals are strong—and progesterone’s “calming” effect is weaker than expected (often described as progesterone resistance)—the endometrium can behave in a more persistently inflamed, reactive way. This hormone–inflammation pattern is especially relevant in estrogen-dependent conditions like adenomyosis and endometriosis, where tissue similar to the endometrium can contribute to ongoing symptoms. If you’re trying to make sense of heavy bleeding, severe cramping, or cycle-linked pelvic pain, our team can help you connect the hormonal biology to what you’re feeling and review next steps for diagnosis and treatment.
What does a frozen uterus mean with endometriosis?
A “frozen uterus” isn’t a separate diagnosis—it’s a descriptive term surgeons use when the uterus is essentially stuck in place because endometriosis-related inflammation has caused dense scarring (adhesions). Instead of the uterus moving freely, it may be tethered to nearby structures like the bowel, bladder, ovaries, or pelvic sidewall, sometimes pulling the uterus into an abnormal position and making pelvic anatomy hard to distinguish.
This finding often suggests more advanced disease, such as deep infiltrating endometriosis and/or significant adhesions from prior inflammation or surgery, and it can help explain symptoms like deep pelvic pain, painful sex, bowel or bladder symptoms, or pain that doesn’t match what a routine exam shows. In these cases, surgery is less about “burning spots” and more about carefully restoring normal anatomy—freeing organs, protecting ureters and bowel, and removing endometriosis at its roots. If you’ve been told your uterus is “frozen,” our team can help you understand what that implies for imaging, surgical planning, and which adjacent organs may need to be evaluated as part of a complete excision strategy.
What are peritoneal pockets in endometriosis?
Peritoneal pockets are small “indentations” or fold-like defects in the peritoneum—the thin lining that covers the pelvic organs and inner abdominal wall. In endometriosis surgery, we may see these pockets as tucked-in areas or little pits in the peritoneal surface, and they can be associated with superficial peritoneal endometriosis or early/developing disease patterns.
These pockets matter because endometriosis doesn’t always look like obvious black or red implants; it can hide within subtle anatomic changes, scarring, or altered peritoneal contours. In the operating room, careful inspection and technique are important so that disease within or around a peritoneal pocket isn’t missed or only treated on the surface. If you’ve been told you have “peritoneal pockets,” our team can help you understand what that finding may mean in your case—based on your symptoms, imaging, and whether deeper structures (like bowel, bladder, or ureters) could also be involved.

